COVID-19 Vaccine For Indirect Protection

Status Withdrawn

Clinical Trial Summary

The primary objective of this study is to test whether vaccinating adults ≥18 years in Hutterite colonies with mRNA-1273 (Moderna COVID-19) vaccine as compared to control (usual care) can prevent RT-PCR confirmed COVID-19 in non-vaccinated Hutterite members.

Clinical Trial Description

Despite the efficacy that has been demonstrated in Phase III randomized controls trials of mRNA COVID-19 vaccines, a critical question that remains unanswered is whether mRNA vaccines lead to herd immunity. The rationale for conducting this study is to learn whether vaccinating adults with a COVID-19 vaccine will prevent COVID-19 infections in non-vaccinated community members. Hutterite communities are unique since they are isolated from towns and cities and also share a number of communal activities, such as eating meals and attending church. Because of their location and practices, the Hutterite colonies give an opportunity to see whether vaccinating some Hutterite members with the COVID vaccine provides protection to the whole group. If the study shows that immunizing some of the population reduces the level of COVID-19 infection for other members of the population, this may be very important in stopping the COVID-19 pandemic and future pandemics. ;

Study Design

Related Conditions & MeSH terms

Vaccine Preventable Disease

Clinical Trial Details

NCT number	NCT04818736
Study type	Interventional
Source	McMaster University
Contact
Status	Withdrawn
Phase	Phase 4
Start date	April 15, 2021
Completion date	December 2021

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04542330` - Using BCG to Protect Senior Citizens During the COVID-19 Pandemic	Phase 3
Completed	`NCT04912661` - Iron and Vaccine Response	N/A
Completed	`NCT04904744` - Effect of Varied Outreach Methods on Appointment Scheduling, Appointment Completion, and Receipt of COVID-19 Vaccination	N/A
Completed	`NCT05462249` - Impact of Catch-up HPV Vaccination
Recruiting	`NCT04899765` - Measles and BCG Vaccines for Mother and Child	Phase 4
Active, not recruiting	`NCT04817917` - Seroprevalence of Neutralizing Antibodies Against Japanese Encephalitis Virus Among 6 Years Old Children With 5 Different Immunization Strategies in Zhejiang Province	Phase 4
Completed	`NCT04944134` - COVID-19 Antibody Levels After Vaccines
Recruiting	`NCT04954092` - Study of Gam-COVID-Vac in Adolescents	Phase 2/Phase 3
Not yet recruiting	`NCT05140720` - Assess the Safety and Immunogenicity of PNEUMOSIL® Vaccine in Healthy Vietnamese Children, 6 Weeks to 24 Months of Age	N/A
Completed	`NCT04765839` - Community-Engaged Bidirectional Pandemic Crisis and Emergency Risk Communication With COVID-19 Vaccine Messages to Minority Populations	N/A
Active, not recruiting	`NCT04953130` - Adding Male Single Dose HPV Vaccination to Female HPV Vaccination in Tanzania	Phase 4